Table 2: Association between current ICS use and COVID-19 Death in ONS - COPD - LAMA monotherapy Population
				Univariable		Age/Sex Adjusted		Age/Sex and Comorbidity Adjusted		
	Events	Person-weeks	Rate per 1,000	HR	95% CI	HR	95% CI	HR	95% CI
LABA/LAMA Combination	163	    747092	0.22	1.00 (ref)		1.00 (ref)		1.00 (ref)
ICS Dual Combination	338	    986485	0.34	1.57	1.30 - 1.89	1.48	1.23 - 1.79	1.41	1.17 - 1.70

